Step 3: Consider Your Health History Any contraindications to either medication
The product should be stored, prepared, and handled only in line with the accompanying instructions
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
The weight-loss results at 48-weeks with the 12 mg dose of retatrutide was an average weight reduction of 24.2%, while the placebo group only saw a 2.1% reduction
References Angl, S., Engblom, J., Eriksson, T., Kautiainen, S., Saha, M.-T., Lindfors, P., Lehtinen, M., & Rimpel, A
Pani A, Gironi I, Di Vieste G, Mion E, Bertuzzi F, Pintaudi B (2020) From prediabetes to type 2 diabetes mellitus in women with polycystic ovary syndrome: lifestyle and pharmacological management